National Institute For Pharmaceutical Technology & Education Inc.

Minneapolis, MN Doing business as Nipte

UEI
RKVKGV1CJDB8
CAGE
4XQ36
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
717 Delaware St SE, Minneapolis, MN 55414, USA
Website
nipte.org
Founded
2005
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About National Institute For Pharmaceutical Technology & Education Inc.

National Institute For Pharmaceutical Technology & Education Inc., doing business as Nipte, is a non-profit collaboration of academia, industry, and other stakeholders that conducts research, outreach, and education to advance pharmaceutical technology.

Through past federal contracts, Nipte has provided research and development services related to continuous drug manufacturing and model-based pharmaceutical production systems to the Food and Drug Administration (FDA). This includes a $3 million contract to perform work on continuous drug substance manufacturing from biomass-derived building blocks in support of the FDA's effort to advance regulatory science. Nipte also received a $5 million contract to take a model-based systems engineering approach to end-to-end liquid pharmaceutical manufacturing. Both contracts were awarded by the FDA through its Broad Agency Announcement mechanism to develop new regulatory science tools and approaches.

Nipte has received federal grants to organize an academic-industry workshop on accelerating drug development and approval, provide thought leadership, and produce a strategic plan to implement workshop findings. It also received a $5.9 million FDA cooperative agreement to develop a platform for reliable analytical and functional characterization of biosimilar drug products. As a subrecipient on federal grants, Nipte has contributed to projects on automated pharmaceutical lyophilization processes and vaccine formulation requirements.

Quick answers

What is National Institute For Pharmaceutical Technology & Education Inc.'s UEI?

National Institute For Pharmaceutical Technology & Education Inc.'s Unique Entity ID (UEI) in SAM.gov is RKVKGV1CJDB8.

What is National Institute For Pharmaceutical Technology & Education Inc.'s CAGE code?

National Institute For Pharmaceutical Technology & Education Inc.'s CAGE code is 4XQ36.

What is National Institute For Pharmaceutical Technology & Education Inc.'s primary NAICS code?

National Institute For Pharmaceutical Technology & Education Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is National Institute For Pharmaceutical Technology & Education Inc. located?

National Institute For Pharmaceutical Technology & Education Inc.'s physical address in SAM.gov is 717 Delaware St SE, Minneapolis, MN 55414, USA.

Is National Institute For Pharmaceutical Technology & Education Inc. registered in SAM.gov?

Yes. National Institute For Pharmaceutical Technology & Education Inc.'s SAM.gov registration is active through April 30, 2027.

What is National Institute For Pharmaceutical Technology & Education Inc.'s most recent federal award?

National Institute For Pharmaceutical Technology & Education Inc.'s most recent federal contract award is BAA contract- FY26C2AP9 advanced CMC index and intelligence platform for drug quality control, shortage prediction,… (75F40126C00069), from Food and Drug Administration, on September 30, 2026.

On GovTribe

See National Institute For Pharmaceutical Technology & Education Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors